Article info
PDFExtended report
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France
- T Lequerré, Rheumatology Department, Rouen University Hospital & Inserm 905, 76031 Rouen, France; thierry.lequerre{at}univ-rouen.fr. Pierre Quartier, Unité d’Immunologie-Hématologie et Rhumatologie pédiatrique, Hôpital Necker-Enfants Malades, 149 rue de Sèvres, 75015 Paris, France; quartier{at}necker.fr
Citation
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France
Publication history
- Accepted September 23, 2007
- First published October 18, 2007.
Online issue publication
May 01, 2023
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group and European League Against Rheumatism